CBLL
CeriBell, Inc.
NASDAQ · USHealthcareMedical - Devices
$18.43-1.55%
Price as of Jul 20, 2026
CBLL profitability
CeriBell, Inc. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 87.7%
- EBITDA margin
- -60.2%
- EBIT margin
- -68.3%
- Net margin
- -63.5%
- Free cash flow margin
- -52.7%
Returns
- Return on equity
- -42.9%
- Return on assets
- -33.9%
- Return on invested capital
- -39.9%
- Asset turnover
- 0.51x
Cash efficiency
- Cash from operations
- -$48.7M
- Cash per share
- $3.72
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.